Seven verifiable checks for the provider, product, evidence and follow-up, with consultation coordination by Khun Kim.
Quick answer
Use seven checks: provider identity, treating physician, cell source and identity, quality testing, regulatory pathway, evidence and costs, and follow-up. Request written answers rather than relying on a package label. Khun Kim can help organise your questions for the Korean team before you commit to travel.
Request the registered provider name, address and treating doctor. A cell company, coordinator and clinic can be different organisations. Establish who assesses you, who administers the product and who handles follow-up, and request documentation relevant to the service.
Ask the source, whether cells are autologous or donor-derived, and whether they are culture-expanded. Discuss viability, sterility testing and batch traceability. Colour in a syringe or an advertised count alone does not establish quality. EHL’s laboratory information is a starting point for asking about your actual batch.
Facility permission, clinical-trial approval and approval of a treatment plan are different. Ask how the proposed administration for your particular goal is authorised. Clear explanations help you understand the medical opportunity and its boundaries.
Request evidence matching the cell product, administration route and patient group, including expected benefits and limitations. A quotation should separate consultation, tests, harvesting, processing, administration, storage and travel. Totals are not comparable when packages contain different items.
Ask for the clinic contact, follow-up timetable and a summary for your doctor at home. Khun Kim can coordinate communication, but treatment changes belong to the physician. The supplied signing photograph documents an activity, not a licence or proof of undisclosed contract terms.
Share your goal, history and recent tests privately through the channel provided by the team for physician review. Include eGFR, creatinine and UACR if relevant and available. Do not post medical records in public comments.
Contact Khun KimOwner-supplied signing photograph, not evidence of regulatory approval · Owner-supplied image; not verification of product identity, licensing or outcomes
Start with the actual clinic and treating doctor, then the cell product and plan documentation.
Not for the whole decision. Also assess indication, regulatory pathway, physician review and follow-up.
By organising questions and coordinating replies from the Korean team; suitability is assessed by the doctor.
5 points • reviewed 2026-11-14
Reviewed and last updated: 2026-11-14
10 sources • every claim is traceable
https://www.ehlbio.co.kr/company/about/
https://www.ehlbio.co.kr/rd/gmp/
https://www.ehlbio.co.kr/company/contact/
https://mohw.go.kr/board.es?act=view&bid=0027&list_no=1483481&mid=a10503000000
https://www.mohw.go.kr/board.es?act=view&bid=0026&list_no=1487217&mid=a10409020000
https://www.ehlbio.co.kr/company/history/
https://www.ehlbio.co.kr/rd/institute/
https://www.ehlbio.co.kr/rd/patent/
https://www.ehlbio.co.kr/conditioned/
https://www.ehlbio.co.kr/immune_cell/
Last updated: 2026-11-14 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories